refractory glioblastoma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadimmunohistochemistry

I am/have/hadpulmonary function test

I am/have/hadleukapheresis

I am/have/hadtargeted therapy

I am/have/hadejection fraction

I am/have/hadcreatinine clearance rate

I am/have/hadinternational normalized ratio

I am/have/hadserum pregnancy test

I am/have/hadneutrophil count

I am/have/hadrefractory glioblastoma

I am/have/hadaptt

I am/have/hadrecurrent disease

I am/have/hadblood cell count

I am/have/hadexpression by immunohistochemistry

I am/have/hadperipheral blood mononuclear cells

I am/have/hadrecurrent glioblastoma

I am/have/hadthromboplastin

I am/have/hadglioblastoma multiforme

added new label for I am/have/had

more

I am looking for

I am looking forbevacizumab

I am looking fortemozolomide

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma

This is a pilot phase I study to evaluate the safety and efficacy on B7-H3 CAR-T in between Temozolomide cycles in treating patients with glioblastoma that has come back or does not respond to the standard treatment. The antigen B7-H3 is highly expressed in glioblastoma of a subset of patients. …

immunohistochemistry

pulmonary function test

targeted therapy

leukapheresis

ejection fraction

0 views
05 Aug, 2020

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.